Injectable antipsychotics better than oral ones at preventing relapse in schizophrenia: Lancet Dr Satabdi Saha21 April 2021 3:00 AM GMTIn a recent development, researchers have noted that, among long-acting injectable antipsychotics (LAIs) and oral antipsychotics in managing...
Insomnia linked to suicidal thoughts in schizophrenia,finds study Dr Satabdi Saha1 April 2021 4:00 AM GMTA recent research reort has confirmed that Insomnia is associated with suicidal ideation, recent suicide attempt, and greater psychopathology in...
Peeking into the shadows of negative symptoms: Avolition plays the lead role? Dr. Shivi Kataria26 March 2021 3:30 PM GMTNegative symptoms are one of the most difficult to treat traits of psychiatric disorders. This calls for a better understanding of their mechanisms...
Redefining real-life functioning in Schizophrenia, study highlights the role of neurocognition Dr. Shivi Kataria26 Feb 2021 1:00 AM GMTSchizophrenia is no longer conceptualized as a progressive deteriorating illness. The clinical stability with persistent symptomatic remission is ...
Seeing schizophrenia: X-rays shed light on neural differences, point toward treatment Hina Zahid24 Feb 2021 4:00 AM GMTSchizophrenia, a chronic, neurological brain disorder, affects millions of people around the world. It causes a fracture between a person's thoughts,...
Liraglutide effective for Weight loss in Patients With Severe Mental Illness MD Bureau12 Feb 2021 2:18 PM GMTThe prevalence of overweight and obesity is 2-3 times higher among people with schizophrenia than in the general population. In a recent study,...
Clozapine effective option for violent schizophrenia patients with conduct disorder Dr. Nandita Mohan3 Feb 2021 4:45 PM GMTIt has been recently observed by the researchers from the Department of Psychiatry, Nathan Kline Institute for Psychiatric Research, Orangeburg, N.Y....
Increased risk of Parkinson's disease in patients with schizophrenia Hina Zahid19 Jan 2021 11:30 AM GMTA new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of...
Early on use of Long-acting antipsychotics reduces hospitalization risk in schizophrenia: JAMA Medha14 Dec 2020 6:42 AM GMTNew York: Long-acting injectable antipsychotics (LAIs) treatment should be considered more broadly for the treatment of early-phase...
Indoco Remedies gets USFDA nod to Olanzapine Tablets to treat schizophrenia, bipolar disorder ruchika9 Aug 2020 4:00 AM GMTMumbai: Indoco Remedies has recently announced receipt of approval for its ANDA for Olanzapine Tablets USP 2.5mg, 5mg, 7.5 mg, 10mg, 15mg and 20 mg.The...
Dexmedetomidine new treatment option for acute agitation in psychiatric disorders Medha8 Aug 2020 4:44 AM GMTSublingual dexmedetomidine is a promising treatment for acute agitation in schizophrenia and bipolar disorder, show results from two pivotal ...
Omega 3 improves memory in patients of schizophrenia with Metabolic syndrome Medha1 July 2020 11:18 AM GMTChina: Omega-3 fatty acids have beneficial effects on cognitive function in patients with schizophrenia and metabolic syndrome (MetS), a recent...
